Pfizer Inc.
PFE
$25.95
$0.160.62%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/29/2026 | 12/31/2025 | 09/28/2025 | 06/29/2025 | 03/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 14.45B | 17.56B | 16.65B | 14.65B | 13.72B |
| Total Other Revenue | 1.00M | -- | -- | -- | -- |
| Total Revenue | 14.45B | 17.56B | 16.65B | 14.65B | 13.72B |
| Cost of Revenue | 3.41B | 5.07B | 3.98B | 3.50B | 2.59B |
| Gross Profit | 11.04B | 12.49B | 12.68B | 11.15B | 11.12B |
| SG&A Expenses | 2.84B | 3.74B | 3.09B | 3.29B | 2.91B |
| Depreciation & Amortization | 1.18B | 1.23B | 1.22B | 1.21B | 1.21B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.88B | 13.35B | 10.78B | 10.45B | 8.89B |
| Operating Income | 4.57B | 4.20B | 5.88B | 4.20B | 4.82B |
| Income Before Tax | 3.17B | -1.64B | 3.33B | 3.04B | 2.78B |
| Income Tax Expenses | 461.00M | -2.00M | -216.00M | 141.00M | -189.00M |
| Earnings from Continuing Operations | 2.71B | -1.64B | 3.55B | 2.90B | 2.97B |
| Earnings from Discontinued Operations | -13.00M | 0.00 | -- | 25.00M | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -8.00M | -8.00M | -9.00M | -18.00M | -6.00M |
| Net Income | 2.69B | -1.65B | 3.54B | 2.91B | 2.97B |
| EBIT | 4.57B | 4.20B | 5.88B | 4.20B | 4.82B |
| EBITDA | 6.18B | 5.86B | 7.53B | 5.83B | 6.44B |
| EPS Basic | 0.47 | -0.29 | 0.62 | 0.51 | 0.52 |
| Normalized Basic EPS | 0.45 | 0.56 | 0.61 | 0.42 | 0.49 |
| EPS Diluted | 0.47 | -0.29 | 0.62 | 0.51 | 0.52 |
| Normalized Diluted EPS | 0.45 | 0.56 | 0.60 | 0.42 | 0.49 |
| Average Basic Shares Outstanding | 5.69B | 5.69B | 5.69B | 5.69B | 5.68B |
| Average Diluted Shares Outstanding | 5.73B | 5.69B | 5.71B | 5.71B | 5.71B |
| Dividend Per Share | 0.43 | 0.86 | 0.43 | 0.43 | 0.43 |
| Payout Ratio | 90.99% | -148.36% | 69.02% | -- | 82.14% |